This result explained that RelB activates HSCs by promoting the release of inflammatory factors and pro‐fibrotic factors in injured hepatocyte, thereby promoting inflammatory response and ECM deposition, ultimately leading to the progression of liver fibrosis. Here, RELB is linked to Hepatic fibrosis.